Janet Sun

Senior Research Assistant @HkuPharm @CSMPR_HKUPharm | All opinions expressed are my own.

[Eric YF Wan @EricWan_HKU]

Our @PLOSMedicine study found that #statin use was associated with reduced risks of #CVDs and all-cause #mortality, including those aged over 85 years with #T2DM, without increased risks for muscle-related adverse events and liver dysfunction observed.
https://t.co/dWSOcTxj4U

[Hei Hang Edmund Yiu @Edmund_Yiu]

I am glad to share our published paper in Value in Health Regional Issues on patient preferences for lipid-lowering agents in hypercholesterolemia using a DCE.

These insights support more patient-centered lipid-lowering strategies and improve adherence. https://t.co/oxRdpM043t

[Eric YF Wan @EricWan_HKU]

Our paper found greater reduction in continuity of care was associated with increased incidences of #CVD, #kidney failure, and #mortality in #DM patients in Hong Kong during #COVID. Contingency plans for primary care in public health #crises is essential.
https://t.co/qfzG9AM7uW

[Eric YF Wan @EricWan_HKU]

Our @CommsMedicine paper found that patients of minor #ailment service #MAS by #community #pharmacists report high levels of #symptom #resolution, #satisfaction, and #enablement, suggesting MAS may alleviate pressure on higher-cost healthcare services.
https://t.co/YtFKGyEGcc

[Eric YF Wan @EricWan_HKU]

Our @Age_and_Ageing paper found that lowering BP of <130/80 mmHg in old and very old patients was associated with better #cardiovascular and #mortality outcomes without increased adverse events, suggesting a lower BP target may be safe for older patients.
https://t.co/6apws5xE5o

[Eric YF Wan @EricWan_HKU]

Our target trial emulation analysis on @NatureComms provides evidence for a BP target of <130/80 mmHg in clinical guidelines for the treatment of adult HT patients in primary care, with a lower risk of HT-related #complications and all-cause #mortality.

https://t.co/FKdSn7pcnx

[Eric YF Wan @EricWan_HKU]

Our interrupted time series analysis on @JournalofNeph illustrates the indirect effect of the #COVID-19 on Chronic Kidney Disease #CKD patients in Hong Kong, as delayed #CVD diagnoses and increased #mortality rate were seen among non-COVID CKD patients.

https://t.co/MH9zY1jGdo

[Eric YF Wan @EricWan_HKU]

Our @amjmed paper confirms the substantial economic burden of smoking to Hong Kong despite its low #smoking prevalence. Healthcare costs for women and middle-aged smokers are disproportionately higher, and targeted #cessation programs can be a solution.

https://t.co/qMEPhV6nLu

[Xinya Mu @Silvia1536629]

Happy to share my first PhD paper in Pharmacological Research 🎉

Using a Japanese claims database, we found that concomitant use of quetiapine and Bupleuri Radix (Chaihu)-containing formulations was associated with increased risk of acute adverse events.

https://t.co/qy8Stf8HLa

[Celine Chui HKU @ChuiCeline]

P-CARDIAC is highly receptive among clinicians and patients. It shows promise in monitoring cardiovascular health and feasibility in implementing in primary care. #AIHealth #cardiology @NatalieTsie @ChunKaWong @hkumed @hku_son @HkuPharm

https://t.co/SGLV8P5DFF

[Claire Cuiling WEI @clairewei0830]

Our paper on trends in migraine-specific medication consumption across 73 countries is out now in Journal of Headache and Pain, as part of the collection “2026 Early Career Research Mentorship Program”. 🎉
🔗https://t.co/Ya0rqrmuX8

[Celine Chui HKU @ChuiCeline]

Our study on repeated antibiotic prescribing in patients living with dementia. While we found no association with seizure or other neuropsychiatric disorders, repeated antibiotic courses were associated with an increased risk of all-cause hospitalization. https://t.co/MfxoeSOmok

[Eric YF Wan @EricWan_HKU]

Our paper in Diabetes Research and Clinical Practice suggests optimising #lipid monitoring frequency by baseline #LDL‑C levels for primary prevention of #cardiovascular disease #CVD in patients with type 2 #diabetes #T2DM.

https://t.co/DVBfdYd0at

[Eric YF Wan @EricWan_HKU]

Our study in @eClinicalMed covering a follow-up period of over 10 years found that #statin therapy in chronic #kidney disease #CKD patients was associated with a small yet significant decrease in all-cause #mortality and a modest #reno-protective effect.

https://t.co/SlV7L5oa38

[Eric YF Wan @EricWan_HKU]

In our #multinational study in @JInternMed, #statin initiation may be associated with increased risk of incident #MyastheniaGravis #MG during the first 6–12 months, with a greater magnitude of risk elevation for higher intensity of statin therapy.
https://t.co/V0t7QlR9a7

[Eric YF Wan @EricWan_HKU]

Our publication at Chinese Journal of General Practitioners introduces #HongKong #Chronic Disease Co-Care Pilot Scheme #CDCC, which can achieve better health outcomes by early #screening and #intervention while lowering overall medical #expenditure.
https://t.co/qEp2b0tFa0

[Eric YF Wan @EricWan_HKU]

We found in the early phase of the #Chronic Disease Co-Care #CDCC Pilot Scheme, #glycemic, #bloodpressure, #lipid, and #BMI indicators improved among #PreDM, #T2DM and #HT patients, with particularly pronounced effects in males and those younger than 65.
https://t.co/u0VbK0cHAa

[Eric YF Wan @EricWan_HKU]

From #HongKong #Chronic Disease Co-Care Pilot Scheme #CDCC participants, our team found that #smoking, physical inactivity, and lower educational level were significant associated factors for #preDM, Type 2 #diabetes #T2DM, and #hypertension #HT. https://t.co/yYtlycaAaP

[Eric YF Wan @EricWan_HKU]

Our paper on @BMCMedicine provides an updated and comprehensive estimate of the #mortality and #morbidity burden associated with #smoking, using a 1.6 million cohort in Hong Kong.
https://t.co/iAeRe8lROj

[Eric YF Wan @EricWan_HKU]

Our @AnnalsofIM paper found that #statins initiation associates with reductions of all-cause #mortality & #CVD in #T2DM adults, including low-risk groups. Results suggest statins initiation in T2DM adults even when short-term predicted CVD #risk is low.
https://t.co/SNCQlHgXVX